Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting neurological disorders. Shows potential in the development of serotonin and dopamine modulators for treating depression and schizophrenia. Also explored for its role in enhancing metabolic stability in central nervous system agents due to its sulfonyl and fluorophenyl groups. Investigated in preclinical studies for anti-inflammatory and analgesic applications.